Skip to main content
. 2021 Nov 8;11:686308. doi: 10.3389/fonc.2021.686308

Figure 3.

Figure 3

Forest plot of response in selected subgroups of patients according to the main clinical and hematological characteristics. For hematologic parameters, we considered pre-therapy values: only 24 patients were considered eligible (three patients were excluded for concomitant hematological tumors, one for thalassemia major, and two patients for concomitant immunosuppressive therapy).